Abpro Holdings, Inc Common Stock
Symbol: ABP (NASDAQ)
0.26
▲ (4.93%) 0.012
Company Description:
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
Key Stats
- Today's Open: $0.2516
- Today's High: $0.267
- Today's Low: $0.25
- Today's Volume: 1.37M
- Yesterday Close: $0.2516
- Yesterday High: $0.2709
- Yesterday Low: $0.2473
- Yesterday Volume: 2.54M
- Last Min Volume: 10
- Last Min High: $0.264
- Last Min Low: $0.264
- Last Min VWAP: $0.264
Company Profile
- Name: Abpro Holdings, Inc Common Stock
- Website: https://www.abpro.co
- Listed Date: 2024-11-13
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001893219
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $16.17M
- Round Lot: 100
- Outstanding Shares: 60.79M
- Asset Type: CS
RECENT FILINGS FOR ABP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-13 | 424B3 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-07 | 4 | View |
| 2025-08-04 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-24 | 8-K | View |
| 2025-06-18 | S-8 | View |
| 2025-06-17 | 8-K | View |
| 2025-06-12 | EFFECT | View |
| 2025-06-12 | 424B3 | View |
| 2025-06-06 | S-1/A | View |
| 2025-05-22 | S-1 | View |
| 2025-05-19 | 4 | View |
| 2025-05-15 | 424B3 | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-05 | EFFECT | View |
| 2025-05-01 | POS AM | View |
| 2025-05-01 | 4 | View |
| 2025-04-30 | ARS | View |
Latest News on ABP